Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
WuXi PharmaTech has strengthened its...
WuXi PharmaTech acquired XenoBiotic...
WuXi PharmaTech, the China CRO with...
WuXi PharmaTech reported Q3 revenues...
WuXi PharmaTech, China's largest...
WuXi PharmaTech filed to list SynTheAll...
With the end of 2014 almost here, WuXi...
To make life easier for its CRO clients,...
WuXi PharmaTech, the China-US CRO/CMO,...
WuXi PharmaTech paid $65 million in cash...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China